Evaluation of the urodynamic and hemodynamic effects of orally administered phenylpropanolamine and ephedrine in female dogs

American Journal of Veterinary Research

Volumn 67, Issue 4, 2006, Pages 723-730

  Carofiglio, Francesca ^a   Hamaide, Annick J ^a   Farnir, Frédéric ^a   Balligand, Marc H ^a   Verstegen, John P ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRINE; PHENYLPROPANOLAMINE; PROPOFOL; VETOQUINOL;

ANESTHESIA INDUCTION; ARTERIAL PRESSURE; ARTICLE; BLADDER SPHINCTER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOG; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEMODYNAMICS; MEAN ARTERIAL PRESSURE; NONHUMAN; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; URETHRA FUNCTION; URETHRA PRESSURE; URODYNAMICS; VENOUS PRESSURE; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; URETHRA;

ANIMALIA; CANIS FAMILIARIS;

ADMINISTRATION, ORAL; ANIMALS; BLOOD PRESSURE; DOGS; EPHEDRINE; FEMALE; HEMODYNAMIC PROCESSES; PHENYLPROPANOLAMINE; URETHRA; URODYNAMICS;

EID: 33646853900     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.4.723     Document Type: Article

References (70)

1. Holt PE. Urinary incontinence in the bitch due to sphincter mechanism incompetence: prevalence in referred dogs and retrospective analysis of 60 cases. J Small Anim Pract 1985;26:181-190.
2. Holt PE, Thrusfield MV. Association in bitches between breed, size, neutering and docking, and acquired urinary incontinence due to incompetence of urethral sphincter mechanism. Vet Rec 1993;133:177-180.
3. Holt PE. Importance of urethral length, bladder neck position and vestibulovaginal stenosis in sphincter mechanism incompetence in the incontinent bitch. Res Vet Sci 1985;39:364-372.
4. Awad SA, Downie JW. Relative contributions of smooth and striated muscles to the canine urethral pressure profile. Br J Urol 1976;48:347-354.
5. Raz S, Caine M, Zeigler M. The vascular component in the production of intraurethral pressure. J Urol 1972;108:93-96.
6. Andersson KE. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 1993;45:253-308.
7. Auguet M, Delaflotte S, Chabrier P-E. Different α1-adrenoceptor subtypes mediate contraction in rabbit aorta and urethra. Eur J Pharmacol 1995;287:153-161.
8. Modiri A-R, Fredrickson MG, Gillberg PG, et al. Selectivity of oxymetazoline for urethral pressure vs blood pressure in the anaesthetized female rabbit. Scand J Urol Nephrol 2000; 34:151-156.
9. Hashimoto S, Kigoshi S, Muramatsu I. Neurogenic responses of urethra isolated from the dog. Eur J Pharmacol 1992;213:117-123.
10. White RA, Pomeroy CJ. Phenylpropanolamine: an α-adrenergic agent for the management of urinary incontinence in the bitch associated with urethral sphincter mechanism incompetence. Vet Rec 1989;125:478-480.
11. Awad SA, Downie JW, Kirulata HG. Pharmacologic treatment of disorders of bladder and urethra: a review. Can J Surg 1979;22:515-518.
12. Jorgensen L, Lose G, Alexander N. Acute effect of norfenefrine on the urethral pressure profile in females with genuine stress incontinence. Urol Int 1991;46:176-179.
13. Lin H-H, Shen B-C, Lo M-C, et al. Comparison of treatment outcomes for imipramine for female genuine stress incontinence. Br J Obstet Gynaecol 1999;106:1089-1092.
14. Finkbeiner AE, Bissada NK. Drug therapy for lower urinary tract dysfunction. Urol Clin North Am 1980;7:3-16.
15. Collste L, Lindskog M. Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients. Urology 1987;30:398-403.
16. Awad SA, Downie JW, Kiruluta HG. Alpha-adrenergic agents in urinary disorders of the proximal urethra. Part I. Sphincteric incontinence. Br J Urol 1978;50:332-335.
17. Ek A, Andersson KE, Ulmsten U. The effects of norephedrine and bethanechol on the human urethral closure pressure profile. Scand J Urol Nephrol 1978;12:97-104.
18. Ek A, Andersson KE, Gullberg B, et al. The effects of long-term treatment with norephedrine on stress incontinence and urethral closure pressure profile. Scand J Urol Nephrol 1978;12:105-110.
19. Richter KP, Ling GV. Clinical response and urethral pressure profile changes after phenylpropanolamine in dogs with primary sphincter incompetence. J Am Vet Med Assoc 1985;187:605-611.
20. Scott L, Leddy M, Bernay F, et al. Evaluation of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch. J Small Anim Pract 2002;43:493-496.
21. Lasagna L. Phenylpropanolamine: a review. New York: John Wiley & Sons, 1988.
22. Hensel P, Binder H, Arnold S. Einfluss von Phenylpropanolamin und Ephedrin auf den urethralen Verschlussdruck und den arteriellen Blutdruck bei kastrierten Hundinnen. Kleintierpraxis 2000;45:617-628.
23. Gillberg PG, Fredrickson MG, Ohman BM, et al. The effect of phenylpropanolamine on the urethral pressure and heart rate is retained after repeated short-term administration in the unanaesthetized, conscious dog. Scand J Urol Nephrol 1998;32:171-176.
24. Montague DK, Stewart BH. Urethral pressure profiles before and after Ornade administration in patients with stress urinary incontinence. J Urol 1979;122:198-199.
25. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-1838.
26. White LM, Gardner SF, Gurley BJ, et al. Pharmacokinetics and cardiovascular effects of Ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol 1997;37:116-122.
27. Haller CA, Jacob P, Benowitz NL. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clin Pharmacol Ther 2004;75:259-273.
28. Vick J, Weiss L, Ellis S. Cardiovascular studies of phenylpropanolamine. Arch Int Pharmacodyn 1994;327:13-24.
29. Khanna OP, Heber D, Gonick P. Cholinergic and adrenergic neuroreceptors in urinary tract of female dogs. Evaluation of function with pharmacodynamics. Urology 1975;5:616-623.
30. Raz S, Caine M. Adrenergic receptors in the female canine urethra. Invest Urol 1972;9:319-323.
31. Sjogren C, Tobin G. An experimental model for long-term examination of urethral and uterine pressures in conscious dogs: effect of a highly selective compound contracting urethral smooth muscles. J Urol 1995;153:201-205.
32. Rosin AH, Ross L. Diagnosis and pharmacological management of disorders of urinary continence in the dog. Compend Contin Educ Pract Vet 1981;3:601-610.
33. Krawiec DR, Rubin SI. Urinary incontinence in geriatric dogs. Compend Contin Educ Pract Vet 1985;7:557-563.
34. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press, 1996;1-125.
35. Johnston S, Root Kustritz M, Olson P. Vaginal cytology. In: Canine and feline theriogenology. Philadelphia: WB Saunders Co, 2001;32-40.
36. Holt PE, Gibbs C, Wathes CM. Simultaneous urethral pressure profilometry using a microtip transducer catheter in the bitch: effects of bitch position and transducer orientation. Neurourol Urodyn 1990;9:281-296.
37. Hamaide AJ, Verstegen JP, Snaps FR, et al. Validation and comparison of the use of diuresis cystometry and retrograde filling cystometry at various infusion rates in female Beagle dogs. Am J Vet Res 2003;64:574-579.
38. International Continence Society. First report on the standardisation of terminology of lower urinary tract function. Br J Urol 1976;48:39-42.
39. Lentner C. Statistical methods. In: Introduction to statistics. Basel, Switzerland: Ciba-Geigy, 1982;182-236.
40. Hussain MA, Aungst BJ, Lam G, et al. Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses. Biopharm Drug Dispos 1987;8:497-505.
41. Wolters M, Methfessel HD, Goepel C, et al. Computer-assisted virtual urethral pressure profile in the assessment of female genuine stress incontinence. Obstet Gynecol 2002;99:69-74.
42. Rao VV, Rambhau D, Rao BR, et al. Pharmacokinetics of a single dose of phenylpropanolamine following oral administration at two different times of the day. Arzneimittelforschung 1998;48:1087-1090.
43. Scherzinger SS, Dowse R, Kanfer I. Steady state pharmacokinetics and dose-proportionality of phenylpropanolamine in healthy subjects. J Clin Pharmacol 1990;30:372-377.
44. Kanfer I, Dowse R, Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy 1993;13:1165-1285.
45. Thiercelin JF, Jacquot C, Rapin JR, et al. Pharmacokinetics of DL-norephedrine 14C in the rat [in French]. Arch Int Pharmacodyn Ther 1976;220:153-163.
46. Lonnerholm G, Grahnen A, Lindstrom B. Steady-state kinetics of sustained-release phenylpropanolamine. Int J Clin Pharmacol Ther Toxicol 1984;22:39-41.
47. Diokno AC, Taub M. Ephedrine in treatment of urinary incontinence. Urology 1975;5:624-625.
48. Fossberg E, Beisland HO, Lundgren RA. Stress incontinence in females: treatment with phenylpropanolamine. A urodynamic and pharmacological evaluation. Urol Int 1983;38:293-299.
49. Kadar N, Nelson JH. Treatment of urinary incontinence after radical hysterectomy. Obstet Gynecol 1984;64:400-405.
50. Andersson KE. Current concepts in the treatment of disorders of micturition. Drugs 1988;35:477-494.
51. Callahan SM, Creed KE. The effects of estrogens on spontaneous activity and responses to phenylephrine of the mammalian urethra. J Physiol 1985;358:35-46.
52. Collins S, Caron MG, Lefkowitz RJ. Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression. Annu Rev Physiol 1991;53:497-508.
53. Lohse MJ. Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1993;1179:171-188.
54. Toews ML, Shreve PE, Bylund DB. Regulation of adrenergic receptors. In: Martinez JR, Edwards BS, Seagrave JC, eds. Signalling mechanisms in secretory and immune cells. San Francisco: San Francisco Press, 1991;1-17.
55. Pickup ME, May CS, Ssendagire R, et al. The pharmacokinetics of ephedrine after oral dosage in asthmatics receiving acute and chronic treatment. Br J Clin Pharmacol 1976;3:123-134.
56. Berlin I, Warot D, Aymard G, et al. Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects. Eur J Clin Pharmacol 2001;57:447-455.
57. Csajka C, Haller CA, Benowitz NL, et al. Mechanistic pharmacokinetics modelling of ephedrine, norephedrine and caffeine in healthy subjects. Br J Clin Pharmacol 2005;59:335-345.
58. Augsburger HR, Cruz-Orive LM, Arnold S. Morphology and stereology of the female canine urethra correlated with the urethral pressure profile. Acta Anat (Basel) 1993;148:197-205.
59. 1-adrenoceptors in urethral function. Eur Urol 1999;36(suppl 1):74-79.
60. Awad SA, Downie JW. The effects of adrenergic drugs and hypogastric nerve stimulation on the canine urethra. A radiologic and urethral pressure study. Invest Urol 1976;13:298-301.
61. Persky AM, Berry NS, Pollack GM, et al. Modelling the cardiovascular effects of ephedrine. Br J Clin Pharmacol 2004;57:552-562.
62. 1-adrenergic receptors and contraction of rat vas deferens. Mol Pharmacol 1983;23:359-368.
63. Persson CGA, Erjefalt I, Keman M. Brompheniramine and the cardio-vascular effects of norephedrine and noradrenaline. Acta Allergol 1973;28:401-415.
64. Stevens MJ, Moulds RF. Heterogeneity of post junctional α-adrenoceptors in human vascular smooth muscle. Arch Int Pharmacodyn Ther 1981;254:43-57.
65. Stevens MJ, Rittinghausen RE, Moulds RFW. Heterogeneity of human vascular pre- and post-synaptic α-adrenoceptors. Clin Sci (Lond) 1981;61(suppl 7):203s-206s.
66. Blackburn GL, Morgan JP, Lavin PT, et al. Determinants of the pressor effect of phenylpropanolamine in healthy subjects. JAMA 1989;261:3267-3272.
67. Kittleson MD, Kienle RD. Syncope. In: Kittleson MD, Kienle RD, eds. Small animal cardiovascular medicine. St Louis: Mosby Inc, 1998;495-501.
68. Claeys MA, Gepts E, Camu F. Haemodynamic changes during anaesthesia induced and maintained with propofol. Br J Anaesth 1988;60:3-9.
69. Michelsen I, Helbo-Hansen HS, Kohler F, et al. Prophylactic ephedrine attenuates the hemodynamic response to propofol in elderly female patients. Anesth Analg 1998;86:477-481.
70. Nakaigawa Y, Akazawa S, Shimuzu R, et al. Effects of graded infusion rates of propofol on cardiovascular haemodynamics, coronary circulation and myocardial metabolism in dogs. Br J Anaesth 1995;75:616-621.